Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

• Hoofdauteurs: Akio Tanaka (Auteur), Ken Igawa (Auteur), Hidetoshi Takahashi (Auteur), Ryosuke Shimizu (Auteur), Yoko Kataoka (Auteur), Hitoe Torisu-Itakura (Auteur), Yoji Morisaki (Auteur), Sonia Montmayeur (Auteur), Norito Katoh (Auteur)
• Formaat: Boek
• Gepubliceerd in: Medical Journals Sweden, 2024-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Lebrikizumab has previously demonstrated efficacy in Phase 3 trials: ADvocate1 and ADvocate2 (as monotherapy), ADhere, and ADhere-J (in combination with topical corticosteroids). Here, the impact of lebrikizumab combined with low- to mid-potency topical corticosteroids on patient-reported outcomes a...